Cite
Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy
MLA
Pooja S. Kumar, et al. “Correction: Evaluation of Bleeding Events in Patients Receiving Acalabrutinib Therapy.” Leukemia, May 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........075beca8f338c3db3fc9f625f9db0419&authtype=sso&custid=ns315887.
APA
Pooja S. Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J. Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A. Bhat, John C. Byrd, Michael R. Grever, Kerry A. Rogers, Jennifer A. Woyach, & Adam S. Kittai. (2023). Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy. Leukemia.
Chicago
Pooja S. Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J. Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, et al. 2023. “Correction: Evaluation of Bleeding Events in Patients Receiving Acalabrutinib Therapy.” Leukemia, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........075beca8f338c3db3fc9f625f9db0419&authtype=sso&custid=ns315887.